Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Gil Bar‐Sela(Emek Medical Center), Moshe Schaffer(Rambam Health Care Campus), Ron Epelbaum(University of Bern)
Cited by 480
Related Papers
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
|Nature Medicine|2019|328
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279